Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization Eileen NicolettiGayatri RaoJonathan D. Schwartz Review Article Open access 17 February 2020 Pages: 913 - 924
Pathophysiology and recent therapeutic insights of sickle cell disease Firdosh ShahMitesh Dwivedi Review Article 10 March 2020 Pages: 925 - 935
Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea Cristiane O. RenóAmanda Rodrigues BarbosaHérica L. Santos Original Article 12 March 2020 Pages: 937 - 945
High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia Igor F. DomingosDiego A. Pereira-MartinsMagnun N. N. Santos Original Article 05 March 2020 Pages: 947 - 953
Targeted next-generation sequencing identified novel mutations associated with hereditary anemias in Brazil M. C. C. M. SvidnickiG. K. ZanettaS. T. O. Saad Original Article Open access 23 March 2020 Pages: 955 - 962
Elevated serum myoglobin levels at hospital admission and the risk of early death among patients with hemophagocytic lymphohistiocytosis: evidence from 155 pediatric patients Xun LiHaipeng YanXiulan Lu Original Article 27 March 2020 Pages: 963 - 971
Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death Gi-June MinByung-Sik ChoHee-Je Kim Original Article 08 April 2020 Pages: 973 - 982
JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis Madhavi MaddaliUday Prakash KulkarniPoonkuzhali Balasubramanian Original Article 10 April 2020 Pages: 983 - 989
Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients Birgit SpiessHelga KleinerWolfgang Seifarth Original Article Open access 06 April 2020 Pages: 991 - 1006
Association between myelofibrosis and risk of non-hematologic malignancies: a population-based retrospective cohort study Walid SalibaMaria KhudyakovaMeir Preis Original Article 10 March 2020 Pages: 1007 - 1016
Genetic polymorphisms and multiple myeloma risk: a meta-analysis Pengcheng ZhangBing Liu Original Article 11 March 2020 Pages: 1017 - 1024
Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple) Eloísa RivaN. SchützD. Fantl Original Article 10 March 2020 Pages: 1025 - 1030
Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis Maximilian MairChristian StrakaDominic Fong Original Article 05 March 2020 Pages: 1031 - 1040
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma Scott R. GoldsmithMark A. FialaRavi Vij Original Article 04 March 2020 Pages: 1041 - 1048
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma Evangelos TerposKarthik RamasamyRoman Hajek Original Article 01 April 2020 Pages: 1049 - 1061
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma Tadao IshidaHideo KimuraKazuyuki Shimizu Original Article 04 April 2020 Pages: 1063 - 1072
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry Karin HohlochChristine Windemuth-KieselbachChristian W. Scholz Original Article Open access 03 March 2020 Pages: 1073 - 1079
Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia Lina van der StratenArnon P. KaterMark-David Levin Original Article 19 March 2020 Pages: 1081 - 1091
Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma Mai TakeuchiHiroaki MiyoshiKoichi Ohshima Original Article 10 March 2020 Pages: 1093 - 1098
Influence of HLA 1–3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation Koji KawamuraJunya KandaYoshinobu Kanda Original Article 23 March 2020 Pages: 1099 - 1110
Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease Haerim ChungJi Eun JangJune-Won Cheong Original Article 06 April 2020 Pages: 1111 - 1119
Histological and magnified endoscopic evaluation of villous atrophy in gastrointestinal graft-versus-host disease Kana MatsudaShoko OnoNaoya Sakamoto Original Article 04 March 2020 Pages: 1121 - 1128
Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia Gopisree PeringethSuchitra SundaramPallawi Torka Letter to the Editor 19 March 2020 Pages: 1129 - 1131
Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL Bernd GruhnGrit BrodtJana Ernst Letter to the Editor Open access 18 February 2020 Pages: 1133 - 1134
Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia Marc SorigueAndrea EspasaJordi Junca Letter to the Editor 13 March 2020 Pages: 1135 - 1136
Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study Jordan BaskettKathryn A. CulosKatie S. Gatwood Letter to the Editor 06 March 2020 Pages: 1137 - 1139
Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia Miao ChenJunling ZhuangBing Han Letter to the Editor 07 March 2020 Pages: 1141 - 1143
A 19-year-old patient with atypical chronic myeloid leukemia Philipp ErnstBjörn EngmannInken Hilgendorf Letter to the Editor Open access 19 March 2020 Pages: 1145 - 1148
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation Roberto CrocchioloAlessio SignoriMauricette Michallet Letter to the Editor 17 March 2020 Pages: 1149 - 1150
Rectal involvement in pre-early T acute lymphoblastic leukemia Roberto MassaiuFrancesco LonguClaudio Fozza Letter to the Editor 16 March 2020 Pages: 1151 - 1152
The clinical significance of the prognostic nutritional index in very elderly patients over 80 years of age with diffuse large B-cell lymphoma Erina HamadaOgura ShinjiTomonori Nakazato Letter to the Editor 08 April 2020 Pages: 1153 - 1155
Successful treatment of intracranial Rosai-Dorfman disease with cytarabine and dexamethasone: case report and review of literature Wei WangJian SunDaobin Zhou Letter to the Editor 31 March 2020 Pages: 1157 - 1159